|
|
Article: RxPedite has signed an agreement with Romark Pharmaceuticals to expand and enhance the company's commercialization efforts in support of Alinia for Oral Suspension, a prescription drug for diarrhea caused by giardia and cryptosporidium in children one through 11 years of age.(Account Wins)(Brief Article)
- Article from:
- Medical Marketing & Media
- Article date:
- June 1, 2004
CopyrightCOPYRIGHT 2004 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RxPedite has signed an agreement with Romark Pharmaceuticals to expand and enhance the company's commercialization efforts in support of Alinia for Oral Suspension, a prescription drug for diarrhea caused by giardia and cryptosporidium in children one through 11 years of age. RxPedite will support Romark in the development and ...